Dzhura Igor, Wu Yuejin, Colbran Roger J, Corbin Jackie D, Balser Jeffrey R, Anderson Mark E
Department of Internal Medicine, Vanderbilt University Medical Center, Vanderbilt University, Nashville, TN 37232-6300, USA.
J Physiol. 2002 Dec 1;545(2):399-406. doi: 10.1113/jphysiol.2002.021881.
A calmodulin (CaM) binding 'IQ' domain on the L-type Ca(2+) channel (LTCC) C terminus and calmodulin kinase II (CaMK) both signal increases in LTCC opening probability (P(o)) by shifting LTCCs into a gating mode (mode 2) with long openings through a process called facilitation. However, the mechanism whereby CaMK and the IQ domain are targeted to LTCCs is unknown. Endogenous CaMK is targeted to LTCCs in excised cell membrane patches because LTCC P(o) increased significantly in CaM-enriched (20 microM) bath solution and this effect was prevented by a specific CaMK inhibitory peptide, but not by an inactive control peptide. Pre-exposure of myocytes to the cytoskeletal disrupting agents nocodazole (microtubule specific) or cytochalasin D (microfilament specific) prevented the effects of CaM-dependent increases in P(o) of LTCCs in excised membrane patches. Neither cytochalasin D nor nocodazole altered the distribution of LTCC gating modes under basal conditions in on-cell mode or excised cell membrane patches, but each of these agents occluded the response of LTCCs to exogenous, constitutively active CaMK and to an IQ-mimetic peptide (IQmp). Cytochalasin D and nocodazole pretreatment also prevented LTCC facilitation that followed a cell membrane depolarizing prepulse. In contrast, cytochalasin D and nocodazole did not affect the increase in LTCC P(o) or prevent the shift to mode 2 gating in response to protein kinase A, indicating that cytoskeletal disruption specifically prevents prepulse, CaMK and IQ-dependent LTCC facilitation.
L型钙通道(LTCC)C末端的钙调蛋白(CaM)结合“IQ”结构域和钙调蛋白激酶II(CaMK)均通过一种称为易化的过程,将LTCC转变为具有长开放时间的门控模式(模式2),从而使LTCC的开放概率(P(o))增加。然而,CaMK和IQ结构域靶向LTCC的机制尚不清楚。内源性CaMK在切除的细胞膜片中靶向LTCC,因为在富含CaM(20微摩尔)的浴液中LTCC的P(o)显著增加,并且这种效应被一种特异性CaMK抑制肽所阻止,而不是被无活性的对照肽所阻止。将心肌细胞预先暴露于细胞骨架破坏剂诺考达唑(微管特异性)或细胞松弛素D(微丝特异性)可阻止切除的膜片中LTCC的P(o)因CaM依赖性增加而产生的效应。在细胞贴附模式或切除的细胞膜片中,细胞松弛素D和诺考达唑在基础条件下均未改变LTCC门控模式的分布,但这些药物中的每一种都阻断了LTCC对外源性组成型活性CaMK和IQ模拟肽(IQmp)的反应。细胞松弛素D和诺考达唑预处理也阻止了细胞膜去极化预脉冲后的LTCC易化。相比之下,细胞松弛素D和诺考达唑不影响LTCC的P(o)增加,也不阻止对蛋白激酶A的反应向模式2门控的转变,这表明细胞骨架破坏特异性地阻止了预脉冲、CaMK和IQ依赖性的LTCC易化。